Shares of Elekta AB (OTCMKTS:EKTAY - Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 9,059 shares changed hands during trading, an increase of 246% from the previous session's volume of 2,617 shares.The stock last traded at $5.93 and had previously closed at $5.8425.
Elekta Price Performance
The company has a current ratio of 0.95, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $2.19 billion, a P/E ratio of -592.41 and a beta of 1.08. The business's fifty day moving average price is $6.10 and its 200-day moving average price is $5.74.
Elekta (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings results on Thursday, March 5th. The company reported $0.09 earnings per share for the quarter. The business had revenue of $433.29 million during the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%. As a group, sell-side analysts predict that Elekta AB will post 0.36 earnings per share for the current fiscal year.
Elekta Company Profile
(
Get Free Report)
Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta's offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.
The company's core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Elekta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta wasn't on the list.
While Elekta currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
